72052022RFI00004: RFI - HIV Care and Treatment
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Guatemala USAID-Guatemala City notices from 2022.
Guatemala USAID-Guatemala City offered grants to the applicants described in the notice. Applications closed on May 27, 2022.
From the official notice on Grants.gov, last changed May 16, 2022. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingRequired
- Funding typeOther
Key dates
| Posted | April 20, 2022 |
|---|---|
| Deadline | May 27, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Local organizations in the Central America Region who possess the capabilities to implement the HIV Care and Treatment Project.
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The United States Government, represented by the Agency for International Development (USAID) in Guatemala is conducting this Request for Information (RFI) to identify local organizations in the Central America Region who possess the capabilities to implement the HIV Care and Treatment Project. El Gobierno de los Estados Unidos, representado por la Agencia para el Desarrollo Internacional (USAID) en Guatemala, está realizando esta Solicitud de Información (RFI) para identificar organizaciones locales en la Región de América Central que posean las capacidades para implementar el Proyecto de Atención y Tratamiento del VIH.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72052022RFI00004 still open?
No. It closed on May 27, 2022.
Who can apply for RFI - HIV Care and Treatment?
Guatemala USAID-Guatemala City accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for RFI - HIV Care and Treatment?
Closed May 27, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)